Literature DB >> 12660235

Characterization of the ligand-binding site of the serotonin 5-HT3 receptor: the role of glutamate residues 97, 224, AND 235.

Christoph Schreiter1, Ruud Hovius, Matteo Costioli, Horst Pick, Stephan Kellenberger, Laurent Schild, Horst Vogel.   

Abstract

Ligand-gated ion channels of the Cys loop family are receptors for small amine-containing neurotransmitters. Charged amino acids are strongly conserved in the ligand-binding domain of these receptor proteins. To investigate the role of particular residues in ligand binding of the serotonin 5-HT3AS receptor (5-HT3R), glutamate amino acid residues at three different positions, Glu97, Glu224, and Glu235, in the extracellular N-terminal domain were substituted with aspartate and glutamine using site-directed mutagenesis. Wild type and mutant receptor proteins were expressed in HEK293 cells and analyzed by electrophysiology, radioligand binding, fluorescence measurements, and immunochemistry. A structural model of the ligand-binding domain of the 5-HT3R based on the acetylcholine binding protein revealed the position of the mutated amino acids. Our results demonstrate that mutations of Glu97, distant from the ligand-binding site, had little effect on the receptor, whereas mutations Glu224 and Glu235, close to the predicted binding site, are indeed important for ligand binding. Mutations E224Q, E224D, and E235Q decreased EC50 and Kd values 5-20-fold, whereas E235D was functionally expressed at a low level and had a more than 100-fold increased EC50 value. Comparison of the fluorescence properties of a fluorescein-labeled antagonist upon binding to wild type 5-HT3R and E235Q, allowed us to localize Glu235 within a distance of 1 nm around the ligand-binding site, as proposed by our model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660235     DOI: 10.1074/jbc.M301801200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors.

Authors:  Russell A Morton; Daniel T Baptista-Hon; Tim G Hales; David M Lovinger
Journal:  Br J Pharmacol       Date:  2015-07-06       Impact factor: 8.739

2.  Thermal unfolding of a mammalian pentameric ligand-gated ion channel proceeds at consecutive, distinct steps.

Authors:  Menno B Tol; Cédric Deluz; Gherici Hassaine; Alexandra Graff; Henning Stahlberg; Horst Vogel
Journal:  J Biol Chem       Date:  2012-12-29       Impact factor: 5.157

3.  Mapping spatial relationships between residues in the ligand-binding domain of the 5-HT3 receptor using a molecular ruler.

Authors:  Heather L Nyce; Spencer T Stober; Cameron F Abrams; Michael M White
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 4.  Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.

Authors:  Tina K Machu
Journal:  Pharmacol Ther       Date:  2011-02-26       Impact factor: 12.310

5.  Subunit rotation models activation of serotonin 5-HT3AB receptors by agonists.

Authors:  Gábor Maksay; Miklós Simonyi; Zsolt Bikádi
Journal:  J Comput Aided Mol Des       Date:  2004-10       Impact factor: 3.686

6.  Bacterially expressed human serotonin receptor 3A is functionally reconstituted in proteoliposomes.

Authors:  Jung-Hyun Na; Jaeil Shin; Yuna Jung; Dongbin Lim; Yeon-Kyun Shin; Yeon Gyu Yu
Journal:  Protein Expr Purif       Date:  2013-01-12       Impact factor: 1.650

7.  Colchicine: a novel positive allosteric modulator of the human 5-hydroxytryptamine3A receptor.

Authors:  A N de Oliveira-Pierce; R Zhang; T K Machu
Journal:  J Pharmacol Exp Ther       Date:  2009-02-02       Impact factor: 4.030

Review 8.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

9.  Histone deacetylase activity is necessary for left-right patterning during vertebrate development.

Authors:  Katia Carneiro; Claudia Donnet; Tomas Rejtar; Barry L Karger; Gustavo A Barisone; Elva Díaz; Sandhya Kortagere; Joan M Lemire; Michael Levin
Journal:  BMC Dev Biol       Date:  2011-05-20       Impact factor: 1.978

10.  The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors.

Authors:  Andrew J Thompson; Mark H P Verheij; Joost Verbeek; Albert D Windhorst; Iwan J P de Esch; Sarah C R Lummis
Journal:  Neuropharmacology       Date:  2014-08-28       Impact factor: 5.250

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.